Catasys, Inc. (CATS)
| Market Cap | 441.67M |
| Revenue (ttm) | 40.62M |
| Net Income (ttm) | -30.33M |
| Shares Out | 17.02M |
| EPS (ttm) | -1.83 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | Jul 6, 2020 |
| Last Price | $25.95 |
| Previous Close | $25.95 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | - |
| Day's Range | 25.31 - 26.65 |
| Day's Volume | 0 |
| 52-Week Range | 8.55 - 32.55 |
News
SANTA MONICA, Calif.--(BUSINESS WIRE)--Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment compa...
SANTA MONICA, Calif.--(BUSINESS WIRE)--Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized outpatient healthcare treatment compa...
Catasys is ramping to hit 2020 guidance even without the Q3 launch of the new national plan.
Catasys's (CATS) CEO Curtis Medeiros on Q1 2020 Results - Earnings Call Transcript
For investors looking for home run hits, these 15 heavily shorted stocks with huge short squeeze potential are worth a look.
Catasys (CATS) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Catasys, Inc. (CATS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Catasys, Inc. (CATS) CEO Terren Peizer on Q4 2019 Results - Earnings Call Transcript
Hidden gem micro-cap stocks are hard to find, unless savvy investors screen for value and strong revenue growth.
Catasys, Inc. (CATS) CEO Terren Peizer on Q3 2019 Results - Earnings Call Transcript
These healthcare stocks are all worth a "buy" now. The healthcare sector will keep chugging along despite market volatility.
Catasys, Inc. (CATS) CEO Terren Peizer on Q2 2019 Results - Earnings Call Transcript
On Wednesday, August 14, Catasys (NASDAQ: CATS) will report its last quarter's earnings.
Catasys (CATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Despite May's large losses, these stocks to buy made new 52-week highs. Maybe this is a signal that they will continue to head higher.
Catasys provides a holistic solution for the most expensive "treatment-avoidant" plan member population, integrating cutting-edge technology with personalized human engagement.
Catasys' (CATS) CEO Terren Peizer on Q1 2019 Results - Earnings Call Transcript
Stocks Moving In Thursday's After-Hours Session
About CATS
Catasys provides big data predictive analytics, artificial intelligence and telehealth, and human intervention services to health plans and other third party payors. The company offers OnTrak solution, which is an integrated suite of services that includes evidence-based psychosocial and medical interventions delivered either in-person or through telehealth, nurse-led care coaching, and local community support. Its OnTrak solution treats members with behavioral conditions, which cause or exacerbate chronic medical conditions, such as diabetes, ... [Read more...]
| Industry Medical Care Facilities | Founded 2003 |
| CEO Terren S. Peizer | Employees 395 |
| Stock Exchange NASDAQ | Ticker Symbol CATS |
Financial Performance
In 2019, Catasys's revenue was $35.10 million, an increase of 131.24% compared to the previous year's $15.18 million. Losses were -$25.66 million, 80.5% more than in 2018.